Cornell’s Employee Excellence Awards go global

More than 75 employees were honored in this year’s ceremony, representing Cornell’s Ithaca campus as well as Weill Cornell Medicine in New York City and Weill Cornell Medicine-Qatar. 

Research Matters: Personalizing pancreatic cancer treatment

Dr. Despina Siolas, assistant professor of medicine at Weill Cornell Medicine and an oncologist at NewYork-Presbyterian/Weill Cornell Medical Center, is working on personalizing treatment for pancreatic cancer, which is often diagnosed too late.

Grants to support research at nexus of AI, climate science

New grant funding will support eight research projects seeking to reduce AI’s energy use and integrate AI in environmental research. 

New immune cell suspects in lupus

The findings could redirect lupus research and open the door to more precise therapies that avoid broad immune suppression.

$7M grant from NASA, Schmidt Sciences to upgrade arXiv

The funding will help arXiv – which is maintained and operated by Cornell Tech – finish migrating to cloud infrastructure and modernizing its code. 

Molecular switch could cause painful side effect of chemo

Chemotherapy activates a stress sensor in immune cells, which may help explain why many cancer patients experience debilitating pain as a side effect, according to Weill Cornell Medicine and Wake Forest University researchers.

CHPC engages business leaders to help inform research initiatives

The Cornell Health Policy Center organized its first Business Leaders Roundtable in New York City last week with the aim of engaging senior industry leaders from the health care sector with existing and upcoming research on topics like Medicare Advantage, Medicaid reform, and prescription drug pricing.

Around Cornell

Reviving exhausted immune cells boosts tumor elimination

A new study shows that tumors not only evade the immune system but can actively reprogram immune cells to stop fighting.

Five questions for: James Grimmelmann

An August article by Grimmelman, co-authored with A. Feder Cooper, Ph.D. ’24, was cited in a landmark European court ruling against OpenAI on Nov. 11.